Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C. +21 more·2020·Annals of Oncology
DOI 10.1016/j.annonc.2019.10.023

Cited by (1,000)

Items 101–200 of 1,000

  1. Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy
    D.L. Delombaerde, Delphine Vervloet, Constantijn Franssen, Lieselot Croes, Félix Gremonprez, Hans Prenen, Marc Peeters, Christof Vulsteke · 2021 · ESMO Open
  2. Cardiovascular toxic effects of antitumor agents: Pathogenetic mechanisms
    Despoina Pantazi, Alexandros D. Tselepis · 2022 · Thrombosis Research
  3. Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments
    Guoxia Zhang, Chao Yuan, Xin Su, Jianzhen Zhang, Priyanka Gokulnath, Gururaja Vulugundam, Guoping Li, Xinyu Yang, Na An, Can Liu et al. · 2022 · Frontiers in Cardiovascular Medicine
  4. A two-phase cuckoo search based approach for gene selection and deep learning classification of cancer disease using gene expression data with a novel fitness function
    Amol Avinash Joshi, Rabia Musheer Aziz · 2024 · Multimedia Tools and Applications
  5. Adjuvant Breast Cancer Treatments Cardiotoxicity and Modern Methods of Detection and Prevention of Cardiac Complications
    Agata Bikiewicz, Maciej Banach, Stephan von Haehling, Marek Maciejewski, Agata Magdalena Bielecka-Dabrowa · 2021 · ESC Heart Failure
  6. Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer
    Sivisan Suntheralingam, Chun‐Po Steve Fan, Oscar Calvillo Arguelles, Husam Mohamed Abdel-Qadir, Eitan Amir, Paaladinesh Thavendiranathan · 2022 · Journal of Clinical Medicine
  7. Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
    Lena Hinrichs, Simone Maria Mrotzek, Raluca‐Ileana Mincu, Julia Pohl, Alina Röll, Lars Michel, Amir Abbas Mahabadi, Fadi Al‐Rashid, Matthias Totzeck, Tienush Rassaf · 2020 · Frontiers in Pharmacology
  8. Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement
    Daniel John Lenihan, Joseph R. Carver, Charles Porter, Jennifer E. Liu, Susan Faye Dent, Paaladinesh Thavendiranathan, Joshua D. Mitchell, Anju Nohria, Michael G. Fradley, Iskra Pusic et al. · 2020 · CA A Cancer Journal for Clinicians
  9. Practical guidance for echocardiography for cancer therapeutics-related cardiac dysfunction
    Tetsuari Onishi, Yuko Fukuda, Sakiko Miyazaki, Hirotsugu Yamada, Hidekazu Tanaka, Jiro Sakamoto, Masao Daimon, Chisato Izumi, Akiko Nonaka, Satoshi Nakatani et al. · 2020 · Journal of Echocardiography
  10. The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
    Héctor Bueno, Brenda Moura, Patrizio Lancellotti, Johann K Bauersachs · 2020 · European Heart Journal
  11. Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade
    Johanna E. J. Jacobs, Wouter L’Hoyes, Lieselotte Lauwens, Yu‐Ling Yu, Marius Brusselmans, Caroline G Weltens, Jens‐Uwe Voigt, Hans P. M. W. Wildiers, Patrick Neven, Joerg Herrmann et al. · 2023 · Journal of the American Heart Association
  12. Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
    Sagar D. Sardesai, Jasmine Singh Sukumar, Mahmoud Attia Mohamed Kassem, Marilly S. Palettas, Julie A. Stephens, Evan Morgan, Daniel Addison, Ragavendra R. Baliga, Daniel G. Stover, Jeffrey Bryan VanDeusen et al. · 2020 · Cardio-Oncology
  13. Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology
    Pouya Joolharzadeh, Mario Rodriguez, Raja Y. Zaghlol, Lauren N. Pedersen, Jesús Jiménez, Carmen R. Bergom, Joshua D. Mitchell · 2023 · Current Cardiology Reports
  14. Estratificación, monitorización y control del riesgo cardiovascular en pacientes con cáncer. Documento de consenso de SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC y AECC
    Ana Martín‐Garcia, Cristina Daniela Mitroi, Pilar Mazón‐Ramos, Ramón García‐Sánz, Juan Antonio Virizuela, Meritxell Arenas, Isabel Egocheaga Cabello, Dimpna Calila Albert, Manuel Anguita Sánchez, Vicente Arrarte et al. · 2021 · Revista Española de Cardiología
  15. Anthracycline Associated Disturbances of Cardiovascular Homeostasis
    Авагимян Ашот Арманович, Lev Kakturskiy, Kiyan Heshmat‐Ghahdarijani, Погосова Нана Вачиковна, Nizal Sarrafzadegan · 2021 · Current Problems in Cardiology
  16. Role of cardiac MRI in the diagnosis of immune checkpoint inhibitor‐associated myocarditis
    Riccardo Cau, Cinzia Solinas, Pushpamali De Silva, Matteo Lambertini, Elisa Agostinetto, Mario Scartozzi, Roberta Montisci, Gianluca Pontone, Michele Porcu, Luca Saba · 2022 · International Journal of Cancer
  17. A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research
    Cameron Brown, Michael D. Mantzaris, Elpiniki Nicolaou, Georgia S. Karanasiou, Elisavet Papageorgiou, Giuseppe Curigliano, Daniela Maria Cardinale, Gerasimos S Filippatos, Nikolaos A Memos, Katerina Κ. Naka et al. · 2022 · Cardio-Oncology
  18. Global Longitudinal Strain in Cardio-Oncology
    Javid J. Moslehi, Ronald M. Witteles · 2021 · Journal of the American College of Cardiology
  19. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
    Ziyu Kuang, Jingyuan Wu, Ying Ching Tan, Guanghui Zhu, Jie Li, Min Wu · 2023 · Biomolecules
  20. Trends in heart disease mortality among breast cancer survivors in the US, 1975–2017
    Jacqueline B. Vo, Cody A. Ramin, Ana Barac, Amy Berrington de González, Lene H.S. Veiga · 2022 · Breast Cancer Research and Treatment
  21. Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
    Dong Wang, Johann K Bauersachs, Dominik Berliner · 2023 · Biology
  22. Advances in the care of breast cancer survivors
    Elizabeth Jane Cathcart-Rake, Amye Juliet Tevaarwerk, Tufia C. Haddad, Stacy D. D’Andre, Kathryn J. Ruddy · 2023 · BMJ
  23. Cardiovascular disease and lung cancer
    Mikhail de Jesus, Anindita Chanda, Titas Grabauskas, Manish Kumar, Agnes S. Kim · 2024 · Frontiers in Oncology
  24. Cardiovascular Complications of Prostate Cancer Treatment
    Michał Wilk, Anna Waśko-Grabowska, Sebastian Szmit · 2020 · Frontiers in Pharmacology
  25. Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data
    Jennifer M. Kwan, Evangelos K. Oikonomou, Mariana L. Henry, Albert J. Sinusas · 2022 · Frontiers in Cardiovascular Medicine
  26. Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers
    Michela Chianca, Giorgia Panichella, Iacopo Fabiani, Alberto Giannoni, Serena L’Abbate, Alberto Aimo, Annamaria Del Franco, Giuseppe Vergaro, Chrysanthos Grigoratos, Vincenzo Castiglione et al. · 2022 · Frontiers in Cardiovascular Medicine
  27. Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
    Aleksandra Sobiborowicz, Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska · 2023 · Cancers
  28. Penguin search optimization algorithm with multi-agent reinforcement learning for disease prediction and recommendation model
    Thota Radha Rajesh, Surendran Rajendran, Meshal Alharbi · 2023 · Journal of Intelligent & Fuzzy Systems · Retracted
  29. Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
    Achraf A. Shamseddine, Suchit H. Patel, Valery A. Chavez, Zachary Moore, Mutayyaba Adnan, Melody Di Bona, Jun Li, Chau T. Dang, Lakshmi V. Ramanathan, Kevin Charles Oeffinger et al. · 2022 · The Journal of Experimental Medicine
  30. Impairment of Hypoxia-Induced CA IX by Beta-Blocker Propranolol—Impact on Progression and Metastatic Potential of Colorectal Cancer Cells
    Monika Baráthová, Katarina Grossmannova, Petra Belvončíková, Veronika Kubasova, Veronika Simko, Rudolf Škubla, Lucia Csáderová, Jaromı́r Pastorek · 2020 · International Journal of Molecular Sciences
  31. Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
    Dongsheng He, Jun Hu, Ying Li, Xiaofei Zeng · 2022 · Frontiers in Cardiovascular Medicine
  32. Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients
    Ying Heng Zhao, Rui He, Sandra Oerther, Weiying Zhou, Massoud Vosough, Moustapha Hassan · 2022 · Journal of Personalized Medicine
  33. Cardiovascular Toxicity of Proteasome Inhibitors in Multiple Myeloma Therapy
    Yi Zheng, Shan Huang, Bingxin Xie, Nan Zhang, Zhiqiang Liu, Gary Tse, Tong Liu · 2022 · Current Problems in Cardiology
  34. Cardiovascular health: an important component of cancer survivorship
    Siobhan Cleary, Stuart David Rosen, Duncan Charles Gilbert, Ruth Elizabeth Langley · 2023 · BMJ Oncology
  35. Cardiotoxicity of Anthracyclines
    Elizabeth M. Balough, Abul Ariza, Aarti H. Asnani, Christopher William Hoeger · 2024 · Cardiology Clinics
  36. Risk prediction models for cancer therapy related cardiac dysfunction in patients with cancer and cancer survivors: systematic review and meta-analysis
    Clara Gomes, Jesse Geels, Thomas P. A. Debray, Arjan Malekzadeh, Folkert Wouter Asselbergs, Marijke Linschoten · 2025 · BMJ
  37. Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
    Maria Isabel Camara Planek, Ahmad S. Manshad, Kyaw Zaw Hein, Mohamad Hemu, Fatima A. Ballout, Rajiv Varandani, Parameswaran Venugopal, Tochukwu M. Okwuosa · 2020 · Cardio-Oncology
  38. Myocardial damage assessed by late gadolinium enhancement on cardiovascular magnetic resonance imaging in cancer patients treated with anthracyclines and/or trastuzumab
    Kalpit Modi, Stephanie Joppa, Ko-Hsuan Amy Chen, Pal Satyajit Singh Athwal, Osama Okasha, Pratik S. Velangi, Matthew C. Hooks, Prabhjot Singh Nijjar, Anne Hudson Blaes, Chetan Shenoy · 2020 · European Heart Journal - Cardiovascular Imaging
  39. Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
    Nathalie I. Bouwer, Tessa Gerjanne Steenbruggen, Joost van Rosmalen, Hánah N. Rier, Jos J. E. M. Kitzen, Marlies L. van Bekkum, Albert J. ten Tije, P. C. de Jong, Jan C. Drooger, Cynthia Holterhues et al. · 2021 · Breast Cancer Research and Treatment
  40. Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children
    Mohamed Hegazy, Stephanie Ghaleb, Bibhuti B. Das · 2023 · Children
  41. Long-term risks of cardiovascular death in a population-based cohort of 1,141,675 older patients with cancer
    Tianwang Guan, Yanting Jiang, Zehao Luo, Yinglan Liang, Manting Feng, Zhenxing Lu, Min Yi, Yintong Teng, Ruoyun Zhou, Liangjia Zeng et al. · 2023 · Age and Ageing
  42. Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023
    Tjoung‐Won Park‐Simon, Volkmar Müller, Christian Jackisch, Ute‐Susann Albert, Malgorzata Joanna Banys-Paluchowski, Ingo Bauerfeind, Jens‐Uwe Blohmer, Wilfried Budach, Peter Dall, Nina Ditsch et al. · 2023 · Breast Care
  43. Microtubule Inhibitors and Cardiotoxicity
    Amogh M. Joshi, George S. Prousi, Christopher Michael Bianco, Midhun Malla, Avirup Guha, Mahek Kishor Shah, Sherry-Ann N. Brown, Brijesh D. Patel · 2021 · Current Oncology Reports
  44. British Society for Echocardiography and British Cardio-Oncology Society guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab
    Rebecca Dobson, Arjun Kumar Ghosh, Bonnie Ky, Thomas Hugh Marwick, Martin Stout, Allan Harkness, Richard Paul Steeds, Shaun Robinson, David Oxborough, David Adlam et al. · 2021 · Echo Research and Practice
  45. Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
    Matthew Anaka, Omar Abdel-Rahman · 2022 · Cancer Management and Research
  46. PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism
    Hao Dong, Yihang Qi, Xiangyi Kong, Zhongzhao Wang, Yi Fang, Jing Wang · 2022 · Frontiers in Pharmacology
  47. Targeting the Renin–angiotensin–aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review
    Jan Pawlonka, Barbara Buchalska, Kasper Buczma, Hubert Borzuta, K. Kamińska, Agnieszka Cudnoch‐Jędrzejewska · 2024 · Current Treatment Options in Oncology
  48. Green synthesis and characterization of iron nanoparticles synthesized from bioflocculant for wastewater treatment: A review
    Nkanyiso C. Nkosi, Albertus K. Basson, Zuzingcebo Goldern Ntombela, Nkosinathi Goodman Dlamini, Viswanadha Srirama Rajasekhar Pullabhotla · 2024 · Biotechnology Notes
  49. Doxorubicin Cardiotoxicity: Pathophysiology Updates
    Christopher William Hoeger, Cole Turissini, Aarti H. Asnani · 2020 · Current Treatment Options in Cardiovascular Medicine
  50. Cardiac Biomarkers During Cancer Therapy
    Jose A. Alvarez-Cardona, Kathleen W. Zhang, Joshua D. Mitchell, Vlad Gabriel Zaha, Michael Jordan Fisch, Daniel John Lenihan · 2020 · JACC CardioOncology
  51. Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology—part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
    Sofie Gevaert, Sigrun Halvorsen, Peter Sinnaeve, Antonia Sambola, Geeta Gulati, Patrizio Lancellotti, Peter van der Meer, Alexander Richard Lyon, Dimitrios T. Farmakis, Geraldine Lee et al. · 2022 · European Heart Journal Acute Cardiovascular Care
  52. Early Diagnostic Value of High-Sensitivity Cardiac Troponin T for Cancer Treatment-Related Cardiac Dysfunction: A Meta-Analysis
    Xinfang Lv, Chenliang Pan, Huan Guo, Juan Chang, Xiang Gao, Xue Wu, Xiaodong Zhi, Chunzhen Ren, Qilin Chen, Hugang Jiang et al. · 2023 · ESC Heart Failure
  53. Cancer Therapy and Exercise Intolerance: The Heart Is But a Part
    Hayley T. Dillon, Stephen Foulkes, Alan H. Baik, Jessica M. Scott, Rhian M. Touyz, Joerg Herrmann, Mark J. Haykowsky, André La Gerche, Erin J. Howden · 2024 · JACC CardioOncology
  54. AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring
    Luiza Nechita, Dana Tutunaru, Aurel Nechita, Andreea Elena Voipan, Daniel Voipan, Ancuta Elena Tupu, Carmina Liana Mușat · 2025 · Diagnostics
  55. Radio-induced cardiotoxicity: From physiopathology and risk factors to adaptation of radiotherapy treatment planning and recommended cardiac follow-up
    Youlia Kirova, Agnes Richard Tallet, Marianne Camille Aznar, Pierre Loap, Anissa Bouali, C. Bourgier · 2020 · Cancer/Radiothérapie
  56. Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease
    Sarju Ganatra, Sourbha S. Dani, Robert Allyn Redd, Kimberly Rieger‐Christ, Rushin P. Patel, Rohan B. Parikh, Aarti H. Asnani, Vigyan V. Bang, Katherine Shreyder, Simarjeet Brar et al. · 2021 · Journal of the National Comprehensive Cancer Network
  57. Traditional markers of cardiac toxicity fail to detect marked reductions in cardiorespiratory fitness among cancer patients undergoing anti-cancer treatment
    Erin J. Howden, Stephen Foulkes, Hayley T. Dillon, Ashley Bigaran, Leah M. Wright, Kristel Janssens, Prue Cormie, Benedict Thomas Costello, André La Gerche · 2021 · European Heart Journal - Cardiovascular Imaging
  58. Cancer treatment-related cardiovascular disease: Current status and future research priorities
    Miki Nonaka, Hiroshi Hosoda, Yasuhito Uezono · 2021 · Biochemical Pharmacology
  59. Eurasian clinical guidelines for cardiovascular complications of cancer treatments: diagnosis, prevention and treatment (2022)
    Irina Evgen'evna Chazova, Fail T. Ageev, Аксенова Анна Владимировна, M.V. Vicenya Vicenya, Mihail Yu. Gilyarov, Tamila Vitalievna Martynyuk, Е. П. Панченко, Maria G. Poltavskaya, Vera I. Potievskaya, Oxana P. Trofimova et al. · 2022 · Eurasian heart journal
  60. Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial
    Evandro de Azambuja, Elisa Agostinetto, Marion Jennifer Procter, Daniel Eiger, Noam Falbel Ponde, Sébastien Guillaume, Damien Parlier, Matteo Lambertini, Ann DeSmet, Carmela Aves Caballero et al. · 2023 · ESMO Open
  61. Cardiovascular Concerns, Cancer Treatment, and Biological and Chronological Aging in Cancer
    Dina Ioffe, Sanjana Bhatia-Patel, Sakshi Gandhi, Eman A Hamad, Efrat Dotan · 2024 · JACC CardioOncology
  62. Cardiac Metastasis: Epidemiology, Pathophysiology, and Clinical Management
    Fabiana Lucà, Iris Parrini, Maria Laura Canale, Carmelo Massimiliano Rao, Mariacarmela Nucara, Giuseppe Pelaggi, Adriano Murrone, Stefano Oliva, Irma Bisceglia, Andrea Sergi et al. · 2025 · Life
  63. Cardiovascular toxicity of angiogenesis inhibitors and immune checkpoint inhibitors: synergistic anti-tumour effects at the cost of increased cardiovascular risk?
    Daan C.H. van Dorst, Leni van Doorn, Katrina M. Mirabito Colafella, Olivier Christiaan Manintveld, H. Carlijne Hassing, A.H. Jan Danser, Ron H.J. Mathijssen, Jorie Versmissen · 2021 · Clinical Science
  64. Cardiac complications associated with hematopoietic stem-cell transplantation
    Akihiro Ohmoto, Shigeo Fuji · 2021 · Bone Marrow Transplantation
  65. New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies
    Oreste Lanza, Armando Ferrera, Simone Reale, Giorgio Solfanelli, Mattia Petrungaro, Giacomo Tini, Massimo Volpe, Allegra Battistoni · 2022 · Medical Sciences
  66. Clinical Practice Guidelines in Cardio-Oncology
    Darryl P. Leong, Daniel John Lenihan · 2022 · Heart Failure Clinics
  67. Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer
    Denise van der Linde, I. van Hagen, Kevin M. Veen, Hanneke J. M. Zuetenhorst, Bas M. van Dalen · 2022 · Netherlands Heart Journal
  68. Anti-breast cancer-induced cardiomyopathy: Mechanisms and future directions
    Chunping Liu, Huiqi Chen, Sien Guo, Qiaojing Liu, Zhijun Chen, Haiding Huang, Qi Zhao, Longmei Li, Huan Cen, Zebo Jiang et al. · 2023 · Biomedicine & Pharmacotherapy
  69. Mediterranean-style dietary interventions in adults with cancer: a systematic review of the methodological approaches, feasibility, and preliminary efficacy
    Aoife McHugh, Ellie O'Connell, Bridie Gurd, Paige Rae, Elena S. George, Amber S. Kleckner, Brenton J. Baguley · 2024 · European Journal of Clinical Nutrition
  70. Long-term and short-term cardiovascular disease mortality among patients of 21 non-metastatic cancers
    Tianwang Guan, Olivia Monteiro, Dongting Chen, Zehao Luo, Kaiyi Chi, Zhihao Li, Yinglan Liang, Zhenxing Lu, Yanting Jiang, Jinming Yang et al. · 2024 · Journal of Advanced Research
  71. Multimodal Fusion Artificial Intelligence Model to Predict Risk for MACE and Myocarditis in Cancer Patients Receiving Immune Checkpoint Inhibitor Therapy
    Chadi Ayoub, Lalith Appari, Milagros Pereyra, Juan Farina, Chieh‐Ju Chao, Isabel G. Scalia, Ahmed Mahmoud, Mohammed Tiseer Abbas, Nima Ali Baba, Jiwoong Jeong et al. · 2024 · JACC Advances
  72. The Role of Speckle Strain Echocardiography in the Diagnosis of Early Subclinical Cardiac Injury in Cancer Patients—Is There More Than Just Left Ventricle Global Longitudinal Strain?
    Michal Laufer‐Perl, Dan Gilon, Livia Kapusta, Zaza Iakobishvili · 2021 · Journal of Clinical Medicine
  73. Quality of life in breast cancer patients with cancer treatment-related cardiac dysfunction: a qualitative study
    Yvonne Koop, N.M. van Zadelhof, Angela H.E.M. Maas, Femke Atsma, Saloua El Messaoudi, Hester Vermeulen · 2021 · European Journal of Cardiovascular Nursing
  74. Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway
    Ferhat Dindaş, Usak-Turkey, Hüseyin Güngör, Mehmet Eki̇ci̇, Pinar Akokay, Füsun Erhan, Mustafa Doğduş, Mehmet Birhan Yilmaz · 2021 · The Anatolian Journal of Cardiology
  75. Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
    Αlexandros Briasoulis, Angeliki M. Chasouraki, Alexandros Sianis, Νικόλαος Παναγιώτου, Christos Kourek, Argyrios Ntalianis, IOANNIS A. PARASKEVAIDIS · 2022 · Journal of Cardiovascular Development and Disease
  76. Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
    Susmita Parashar, Nausheen Akhter, Elisavet Paplomata, Islam Y. Elgendy, Deepa Upadhyaya, Marielle Scherrer‐Crosbie, Tochukwu M. Okwuosa, Rupa Mehta Sanghani, Eva Chalas, Kathryn J. Lindley et al. · 2023 · JACC CardioOncology
  77. Cardiotoxicity in HER2-positive breast cancer patients
    Diana Gonciar, Lucian Constantin MOCAN, Alexandru Zlibut, Teodora Mocan, Lucia Agoşton-Coldea · 2021 · Heart Failure Reviews
  78. Genetic factors in the pathogenesis of cardio-oncology
    Yalong Qi, Yuhan Wei, Lixi Li, Hewei Ge, Yuanyi Wang, Cheng Zeng, Fei Ma · 2024 · Journal of Translational Medicine
  79. Quality-of-Care Measures for Cardio-Oncology
    Vijay U. Rao, Anita M Deswal, Daniel John Lenihan, Susan Faye Dent, Teresa López‐Fernández, Alexander Richard Lyon, Ana Barac, Nicolas L. Palaskas, Ming Hui Chen, Hector R. Villarraga et al. · 2025 · JACC CardioOncology
  80. Radiation-induced cardiac substructure damage and dose constraints: a review
    Xinyi Li, Yajing Wu, Qingyu Wang, Bingyue Li, Jun Wang · 2025 · Radiation Oncology
  81. Incidence trends and long-term survival in early-onset colorectal cancer: a nationwide Swedish study
    Shabane Barot, Annelie Liljegren, Caroline A.M. Nordenvall, Johannes Blom, Cecilia Radkiewicz · 2025 · Annals of Oncology
  82. Cardiovascular Toxicity and Mortality Associated With Adoptive Cell Therapy and Tumor-infiltrating Lymphocytes for Advanced Stage Melanoma
    Michael G. Fradley, Rongras Damrongwatanasuk, Sanjay Amrith Chandrasekhar, Mohammed Alomar, Kevin E. Kip, Amod A. Sarnaik · 2020 · Journal of Immunotherapy
  83. Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity
    Shane S. Scott, Ashley N. Greenlee, Anna Matzko, Matthew Stein, Michael T. Naughton, Taborah Z. Zaramo, Ethan J. Schwendeman, Somayya J. Mohammad, Mamadou Diallo, Rohith Revan et al. · 2022 · Heart Failure Clinics
  84. Can Dietary Nutrients Prevent Cancer Chemotherapy-Induced Cardiotoxicity? An Evidence Mapping of Human Studies and Animal Models
    Xinyu Zhang, Ke-Lu Yang, Yang Li, Yang Zhao, Kewei Jiang, Quan Wang, Xiao-Nan Liu · 2022 · Frontiers in Cardiovascular Medicine
  85. When Cancer and Cardiovascular Disease Intersect: The Challenge and the Opportunity of Cardio-Oncology
    Aaron Leonid Sverdlov, Bogda Koczwara, D. Cehic, Robyn A. Clark, Lee Hunt, Stephen James Nicholls, Liza Thomas, Elysia Thornton‐Benko, Leonard Kritharides · 2023 · Heart Lung and Circulation
  86. Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study
    Zehao Luo, Kaiyi Chi, Hongjun Zhao, Linglong Liu, Wenting Yang, Zhijuan Luo, Yinglan Liang, Liangjia Zeng, Ruoyun Zhou, Manting Feng et al. · 2023 · Frontiers in Cardiovascular Medicine
  87. A practical approach to the 2022 ESC cardio-oncology guidelines: Comments by a team of experts – cardiologists and oncologists
    Przemysław Leszek, Aneta Klotzka, Stanisław Bartuś, Paweł Burchardt, Anna Malgorzata Czarnecka, Monika Długosz‐Danecka, Marek J. Gierlotka, Hanna Koseła-Paterczyk, Agata Krawczyk‐Ożóg, Tomasz Kubiatowski et al. · 2023 · Kardiologia Polska
  88. A Comprehensive Review of Cancer Drug–Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies
    Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, Rakesh Kumar Acharya, Lakkakula VKS Bhaskar, Henu Kumar Verma · 2024 · Current Treatment Options in Oncology
  89. Chronic myeloid leukaemia: Biology and therapy
    Yun Wang, Zhi-Jian Liang, Robert Peter Gale, Huaze Liao, Jun Ma, Tiejun Gong, Yingqi Shao, Yang Liang · 2024 · Blood Reviews
  90. Echocardiographic evaluation of patients undergoing cancer therapy
    Maria Klara Frey, Jutta K Bergler-Klein · 2020 · European Heart Journal - Cardiovascular Imaging
  91. Cancer therapeutics-related cardiovascular dysfunction: Basic mechanisms and clinical manifestation
    Masayoshi Oikawa, Takafumi Ishida, Yasuchika Takeishi · 2022 · Journal of Cardiology
  92. Cardiac MRI assessment of anthracycline-induced cardiotoxicity
    Leila Mabudian, Jennifer H. Jordan, Wendy J. Bottinor, William Gregory Hundley · 2022 · Frontiers in Cardiovascular Medicine
  93. Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma
    Beata Franczyk, Jacek Rysz, Janusz Ławiński, Aleksandra D. Ciałkowska-Rysz, Anna Gluba-Brzózka · 2023 · Biomedicines
  94. Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation
    Lloyd E. Butel-Simoes, Tatt Jhong Haw, Trent D. Williams, Shanathan Sritharan, Payal Gadre, Sandra M. Herrmann, Joerg Herrmann, Doan T M Ngo, Aaron Leonid Sverdlov · 2023 · Hypertension
  95. Inflammatory Biomarkers in Assessing Severity and Prognosis of Immune Checkpoint Inhibitor-Associated Cardiotoxicity
    Lin Liang, Chanjuan Cui, Dan Lv, Yiqun Li, Liyan Huang, Jiayu Feng, Tao An, Pengchao Tian, K. G. Yang, Linjun Hu et al. · 2023 · ESC Heart Failure
  96. Global longitudinal strain as an early marker of cardiac damage after cardiotoxic medications, a state-of-the-art review
    Andrea Sartorio, Luca Cristin, Chiara Dal Pont, Afshin Farzaneh‐Far, Simone Lorenzo Romano · 2025 · Progress in Cardiovascular Diseases
  97. Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial
    I. Meattini, C. Becherini, Francesco Martella, Maria Riccarda Del Bene, C. Saieva, Carlotta Bacci, Luigi Coltelli, G. Pilato, L. Visani, Viola Salvestrini et al. · 2025 · ESMO Open
  98. Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
    Agneta Månsson‐Broberg, Jürgen Geisler, SUVI SIRKKU TUOHINEN, Tanja Skyttä, Þórdís Jóna Hrafnkelsdóttir, Kirsten Melgaard Nielsen, Elham Hedayati, Torbjørn Omland, Birgitte Vrou Offersen, Alexander Richard Lyon et al. · 2020 · Current Heart Failure Reports
  99. Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques
    Daniela Di Lisi, Girolamo Manno, Giuseppina Novo · 2021 · Current Problems in Cardiology
  100. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
    Ana Martín‐Garcia, Cristina Daniela Mitroi, Pilar Mazón‐Ramos, Ramón García‐Sánz, Juan Antonio Virizuela, Meritxell Arenas, Isabel Egocheaga Cabello, Dimpna Calila Albert, Manuel Anguita Sánchez, Vicente Ignacio Arrarte Esteban et al. · 2021 · Revista Española de Cardiología (English Edition)